World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23780
World Ranking
16158
National Ranking
610

Jelle Wesseling publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jelle Wesseling sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 602 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jelle Wesseling D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jelle Wesseling sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jelle Wesseling is affiliated with Leiden University Medical Center in the Netherlands and has a substantial research output in the fields of medicine, biochemistry, genetics, and molecular biology. Their work primarily focuses on oncology, with significant contributions to cancer research, radiology, nuclear medicine, imaging, molecular biology, and pathology.

The scientist's recent publications include studies published in prominent journals exploring breast cancer and its various aspects. Selected papers are:

  • "Personalized early detection and prevention of breast cancer: ENVISION consensus statement," 2020, Nature Reviews Clinical Oncology
  • "Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study," 2021, Journal of Hematology & Oncology
  • "The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands," 2020, Journal of Hematology & Oncology
  • "Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of DualERBB2Blockade in Patients WithERBB2-Positive Breast Cancer," 2021, JAMA Oncology
  • "Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy," 2022, Zurich Open Repository and Archive (University of Zurich)

Their extensive collaboration network includes multiple frequent co-authors, such as:

  • Esther H. Lips
  • Marjanka K. Schmidt
  • Alastair M. Thompson
  • Gabe S. Sonke
  • Lodewyk F.A. Wessels

Jelle Wesseling's publications are frequently found in leading oncology and cancer research journals, reflecting the focal points of their research. Common venues include:

  • Cancer Research
  • European Journal of Cancer
  • npj Breast Cancer
  • Clinical Cancer Research
  • British Journal of Cancer

The primary fields of study encompass:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, subfields addressed by their work comprise:

  • Oncology
  • Cancer Research
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Pathology and Forensic Medicine

The scientist's main topics of research include:

  • Breast Cancer Treatment Studies
  • Global Cancer Incidence and Screening
  • Cancer Genomics and Diagnostics
  • Breast Lesions and Carcinomas
  • Radiomics and Machine Learning in Medical Imaging
  • HER2/EGFR in Cancer Research
  • AI in cancer detection

Best Publications

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

    Chong Sun;Liqin Wang;Sidong Huang;Guus J. J. E. Heynen

  • Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

    J Wesseling;S W van der Valk;H L Vos;A Sonnenberg

  • A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

    J Wesseling;S W van der Valk;J Hilkens

  • Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

    Mila Donker;Marieke E. Straver;Jelle Wesseling;Claudette E. Loo

  • Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study

    Lotte E. Elshof;Konstantinos Tryfonidis;Leen Slaets;A. Elise van Leeuwen-Stok

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.

    Mathilde Jalving;Jan Koornstra;J. Wesseling;Hendrika Boezen

  • Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.

    Siân Jones;Meng Li;D. Williams Parsons;Xiaosong Zhang

  • Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

    Jolien M. Bueno-de-Mesquita;Wim H. van Harten;Valesca P. Retel;Laura J. van't Veer

  • Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

    Claudette E. Loo;Marieke E. Straver;Sjoerd Rodenhuis;Sara H. Muller

  • The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

    Marieke E. Straver;Annuska M. Glas;Juliane Hannemann;Jelle Wesseling

  • Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

    Mette S van Ramshorst;Anna van der Voort;Erik D van Werkhoven;Ingrid A Mandjes

  • A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

    C.A. Drukker;J.M. Bueno-de-Mesquita;V.P. Retèl;W.H. van Harten

  • Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

    Nora Pashayan;Antonis C. Antoniou;Urska Ivanus;Laura J. Esserman

  • Tissue distribution of the death ligand TRAIL and its receptors

    Diana C. Spierings;Elisabeth G. de Vries;Edo Vellenga;Fiona A. van den Heuvel

  • Receptor conversion in distant breast cancer metastases

    Laurien D.C. Hoefnagel;Marc J. van de Vijver;Henk Jan van Slooten;Pieter Wesseling

  • Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers.

    E H Lips;L Mulder;A Oonk;L E van der Kolk

  • Ductal carcinoma in situ: to treat or not to treat, that is the question

    Maartje van Seijen;Esther H. Lips;Alastair M. Thompson;Serena Nik-Zainal

  • Tumour-specific proline vulnerability uncovered by differential ribosome codon reading

    Fabricio Loayza-Puch;Koos Rooijers;Levi C. M. Buil;Jelle Zijlstra

Frequent Co-Authors

Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Jos Jonkers
Jos Jonkers Antoni van Leeuwenhoek Hospital
Paul J. van Diest
Paul J. van Diest Utrecht University
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital
Anna Sapino
Anna Sapino University of Turin
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond medical school, there are several online degree and certificate programs that offer flexible and affordable options. Many roles in the US healthcare system require specialized education, but do not necessarily require a full MD.

For example, a bachelor of health information management online can lead to opportunities in managing patient records, data privacy, and healthcare analytics. Those looking for a quick entry into the field might consider a medical coding certification, preparing you for roles that support hospitals and practices with insurance claims and classifications.

Nursing remains a popular route for those passionate about patient care. Choosing the cheapest np school can help you become a nurse practitioner, a role in high demand across the US. Likewise, the cheapest online msn programs enable registered nurses to advance to leadership, education, or specialized clinical roles—all while studying remotely.

These diverse, accredited online pathways can help you build a meaningful healthcare career while balancing work, family, and other commitments.

Best Scientists Citing Jelle Wesseling

Trending Scientists

Recently Published Articles